By analyzing the data from TCGA database and validating the results in the TMA samples, we found lower Sema3D expression in ccRCC tumor tissues than para-tumor tissues, and low Sema3D level was associated with poor prognosis in ccRCC patients. This evidence concerns the gene SEMA3D and nonpapillary renal cell carcinoma.